Stockreport

Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now? [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF I'm talking about the weight loss drug market -- one that Morgan Stanley analysts say may multiply by 15 to surpass $100 billion later this decade. Viking doesn't sell [Read more]